Point72 »

C4 Therapeutics shares owned by Point72

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by Point72 from 13F filings

Historical chart of Point72 investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by Point72 consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by Point72

Quarter filed Position value Share count Share price at filing
2024-12-31 $41k 11k 3.60
2024-09-30 $51k 8.9k 5.70

More positions owned by Point72

Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Amgen Call Option (AMGN)
Spdr Dow Jones Indl Average Ut Ser 1 (DIA)
McKesson Corporation (MCK)
Ishares Tr Russell 2000 Etf Call Option (IWM)
NVIDIA Corporation (NVDA)
Adobe Systems Incorporated Call Option (ADBE)
salesforce (CRM)
Target Corporation Call Option (TGT)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Analog Devices (ADI)
Micron Technology (MU)
Bristol Myers Squibb (BMY)
Cisco Systems (CSCO)
Walt Disney Company (DIS)

View all positions for Point72

Top funds holding C4 Therapeutics

Soleus Capital Management
Lynx1 Capital Management
Daniel D. Thurber
BlackRock
RA Capital Management
OrbiMed Advisors
Morgan Stanley
Commodore Capital
Vanguard Group
Samlyn Capital
Bank of America Corporation
Adage Capital Partners GP
Geode Capital Management
Arrowpoint Asset Management
Silverarc Capital Management

View all funds holding C4 Therapeutics